Can Alzheimer’s Be Detected Before Symptoms Appear

Early Warning Signs And Diagnosis

Alzheimers Disease can be caught in the early stageswhen the best treatments are availableby watching for telltale warning signs. If you recognize the warning signs in yourself or a loved one, make an appointment to see your physician right away. Brain imaging technology can diagnose Alzheimers early, improving the opportunities for symptom management.

Key Points About Early

• Alzheimer disease commonly affects older people, but early-onset Alzheimer disease can affect people in their 30s or 40s.

• It affects memory, thinking, and behavior.

• Although there is no known cure, early diagnosis and treatment can lead to better quality of life.

• Stay healthy with a good diet and regular exercise.

• Avoid alcohol and other substances that may affect memory, thinking, and behavior.

Why Is Early Detection Of Alzheimers Important

Most often, someone finds out she has Alzheimers when her symptoms become apparent, either to her or her loved one. She is noticeably losing cognitive function. She is forgetting simple things. She is feeling disoriented or getting lost. By this point, Alzheimers disease has already set in and early treatments that can help slow the disease may not be as helpful.

However, if Alzheimers is detected before any symptoms appear, the course of treatment is much more effective. You can go on medications early to slow the process of cognitive decline, giving you more years of good memory. You and your loved ones can be prepared for the future, making key decisions regarding caregiving and memory care facility options. And you can be a part of those decisions. You can also participate in clinical trials.

Alzheimers research is robust and aggressive. You could be a part of a breakthrough treatment or therapy.

But all of this depends on early detection.

Recommended Reading: How Can A Dietitian Help Someone With Dementia

New Blood Marker Renews Hope For Blood Test To Detect Alzheimers

Another study from the University of Otago has also revealed another blood marker that could help diagnose Alzheimers through a simple blood test. Researchers found that participants with a small number of molecules found in the blood and brain called microRNAs can correctly detect Alzheimers with 86% accuracy.

This study involved participants that had been diagnosed with the disease, as well as neurologically healthy individuals. Researchers found that three microRNAs were different between the two groups and detecting these microRNAs would be possible through a simple blood test. Dr. Joanna Williams, who led the screening of microRNA in blood samples of participants, says, Although there are other known markers of early Alzheimers disease, such as an accumulation of the protein beta-amyloid in the brain, testing for these involves expensive or invasive procedures that cant be used in routine clinical practice.

Dr. Williams went on to state, We know that the levels of these microRNAs differ in people who have Alzheimers and people who dont. So if a general practitioner took a blood sample from a patient who was beginning to show symptoms of memory loss, what wed do is analyze that blood and see how that patients pattern of microRNA compares against established patterns.

New Study: Blood Test Could Predict Alzheimer’s 16 Years Before Symptoms Appear

The brain damage that leads to Alzheimer’s can be detected with a simple blood test up to 16 years before symptoms appear, according to a study published recently in the journal Nature Medicine and reported on by CNN, The Today Show and USA Today. Dr. Stephen Salloway, director of the Memory and Aging Program at Butler Hospital, is among the authors of the paper. The study was conducted through the Dominantly Inherited Alzheimer’s Network , an international consortium of researchers investigating the development of genetically inherited Alzheimer’s disease. The Memory and Aging Program is a DIAN member and study site.

“A blood test for Alzheimer’s would be a game-changer with regard to detecting people at risk, so the results of this study mark a major breakthrough in the field,” Dr. Salloway said.

The study measured the levels of a protein in the blood called Neurofilament light chain , which is an indication of nerve cell loss in the brain. Elevated levels of this protein indicate brain damage. The study showed that a continuing rise in the level of NfL can serve as a biomarker of developing Alzheimer’s disease.

As shared in this release by the study’s lead research site, the Washington University School of Medicine:

Don’t Miss: Can Dementia Cause Hair Loss

Alzheimers The Disease That Can Now Be Detected 20 Years Before The Appearance Of Symptoms

Los screening criteria for Alzheimers disease, the most frequent of dementias, underwent a profound transformation in the last decade to the point that today it is possible to reach a presumptive diagnosis between 15 and 20 years before the first clinical symptoms of memory loss appear, according to specialists explained on the eve of World Day.

This entire revolution took place thanks to the identification of biomarkers or biological indicators -such as the TAU protein and amyloid beta- present during its silent phase or preclinical phase, which can precede that of observable external symptoms by up to two decades. .

The most novel thing in terms of diagnosis is that today there are biomarkers that allow something surreal, which is to diagnose the disease with certainty and early before it happens, he told Télam. psychiatrist and dean of the Faculty of Medicine at UBA Ignacio Brusco.

From there, its possible delay that onset through a combination of high-tech medicine and primary care techniqueswhich results in a longer survival and better quality of life.

For your part neurologist Juan Ollariwho is in charge of the Cognitive Neurology Center of the British Hospital in Buenos Aires, explained that although diagnostic criteria have changed worldwide and today they are based above all on biomarkers traceable through imaging studies or cerebrospinal fluid, these are still not approved for clinical use by Anmat.

Introduced In Sweden Last Year

The one blood test that the researchers developed has been in clinical use in Sweden since 2020. It measures NFL, a marker for nerve cell damage in the brain.

The other measures phosphorylated tau, a marker of changes in the brain that are specific to Alzheimer’s. Blennow expects this test to be approved for clinical use during 2021.

Its easy to send blood samples, and we also have the capacity to analyse samples from neighbouring countries such as Norway, says Blennow.

Blennow says its most relevant for a person to be tested if they notice that their memory is bad. Those who are tested can then be offered experimental treatment with promising drugs.

There are several different, promising drugs in development. One has been submitted for approval to the US Food and Drug Administration, he said.

Before these drugs can be used on a large scale in Norway and Sweden, however, they have to be approved by each country’s state drug agency.

You May Like: How To Get Help For Alzheimer’s Patients

What Happens If A Doctor Thinks It’s Alzheimer’s Disease

If a primary care doctor suspects Alzheimers, he or she may refer the patient to a specialist who can provide a detailed diagnosis or further assessment. Specialists include:

• Geriatricians, who manage health care in older adults and know how the body changes as it ages and whether symptoms indicate a serious problem.
• Geriatric psychiatrists, who specialize in the mental and emotional problems of older adults and can assess memory and thinking problems.
• Neurologists, who specialize in abnormalities of the brain and central nervous system and can conduct and review brain scans.
• Neuropsychologists, who can conduct tests of memory and thinking.

Memory clinics and centers, including Alzheimers Disease Research Centers, offer teams of specialists who work together to diagnose the problem. In addition, these specialty clinics or centers often have access to the equipment needed for brain scans and other advanced diagnostic tests.

What Are The Symptoms Of Early

For most people with early-onset Alzheimer disease, the symptoms closely mirror those of other forms of Alzheimer disease.

Early symptoms:

• Withdrawal from work and social situations

• Changes in mood and personality

Later symptoms:

• Severe mood swings and behavior changes

• Deepening confusion about time, place, and life events

• Suspicions about friends, family, or caregivers

• Trouble speaking, swallowing, or walking

• Severe memory loss

You May Like: How Does Someone Get Diagnosed With Dementia

Health Environmental And Lifestyle Factors That May Contribute To Alzheimer’s Disease

Research suggests that a host of factors beyond genetics may play a role in the development and course of Alzheimer’s disease. There is a great deal of interest, for example, in the relationship between cognitive decline and vascular conditions such as heart disease, stroke, and high blood pressure, as well as metabolic diseases, such as diabetes and obesity. Ongoing research will help us understand whether and how reducing risk factors for these conditions may also reduce the risk of Alzheimer’s.

A nutritious diet, physical activity, social engagement, sleep, and mentally stimulating pursuits have all been associated with helping people stay healthy as they age. These factors might also help reduce the risk of cognitive decline and Alzheimer’s disease. Clinical trials are testing some of these possibilities.

Early-life factors may also play a role. For example, studies have linked higher levels of education with a decreased risk of dementia. There are also differences in dementia risk among racial groups and sexesall of which are being studied to better understand the causes of Alzheimers disease and to develop effective treatments and preventions for all people.

What Causes Alzheimers Disease

In recent years, scientists have made tremendous progress in better understanding Alzheimers and the momentum continues to grow. Still, scientists dont yet fully understand what causes Alzheimers disease in most people. In people with early-onset Alzheimers, a genetic mutation may be the cause. Late-onset Alzheimers arises from a complex series of brain changes that may occur over decades. The causes probably include a combination of genetic, environmental, and lifestyle factors. The importance of any one of these factors in increasing or decreasing the risk of developing Alzheimers may differ from person to person.

The basics of Alzheimers disease

Scientists are conducting studies to learn more about plaques, tangles, and other biological features of Alzheimers disease. Advances in brain imaging techniques allow researchers to see the development and spread of abnormal amyloid and tau proteins in the living brain, as well as changes in brain structure and function. Scientists are also exploring the very earliest steps in the disease process by studying changes in the brain and body fluids that can be detected years before Alzheimers symptoms appear. Findings from these studies will help in understanding the causes of Alzheimers and make diagnosis easier.

Alzheimer’s disease genetics

Scientists also have identified several regions of interest in the genome that may increase or decrease a persons risk for late-onset Alzheimers to varying degrees.

Recommended Reading: What’s The Symptoms Of Alzheimer’s

An Alzheimers Warning 25 Years Before Symptoms Show

• Karen Weintraubarchive page

The first detectable signs of Alzheimers disease occur as long as a quarter century before symptoms like memory loss become noticeable, according to a detailed chronology of molecular changes to the brain and spinal fluid of people who later developed the brain disease.

The research, published today in the New England Journal of Medicine, provides a timeline of the subtle changes that begin in victims brains and, importantly, can be detected years ahead of time by MRI exams, blood analyses, or other tests.

The development of biomarkers that can track and predict the natural course of the disease is important for carrying out drug studies, in part because changes to these molecules could give early hints that a drug works. Treatments for Alzheimers have all been unsuccessful so farin part, researchers think, because people received drugs only after symptoms had become obvious and their brains were too damaged to recover.

This is perhaps the most comprehensive picture of what changes, in what order, and by how much, says Randall Bateman, a professor of neurology at Washington University School of Medicine, and the studys first author.

A combination of factors similar to those that lead to heart diseasediabetes, poor diet, lack of exerciseare associated with the development of Alzheimers, although the diseases root cause is still a matter of scientific debate.

Other Factors That Can Affect Behavior

In addition to changes in the brain, other things may affect how people with Alzheimers behave:

• Feelings such as sadness, fear, stress, confusion, or anxiety
• Health-related problems, including illness, pain, new medications, or lack of sleep
• Other physical issues like infections, constipation, hunger or thirst, or problems seeing or hearing

Other problems in their surroundings may affect behavior for a person with Alzheimers disease. Too much noise, such as TV, radio, or many people talking at once can cause frustration and confusion. Stepping from one type of flooring to another or the way the floor looks may make the person think he or she needs to take a step down. Mirrors may make them think that a mirror image is another person in the room. For tips on creating an Alzheimers-safe home, visit Home Safety and Alzheimers Disease.

If you dont know what is causing the problem, call the doctor. It could be caused by a physical or medical issue.

Recommended Reading: How To Deal With Abusive Dementia Patients

Difficulty Determining Time Or Place

Losing track of dates and misunderstanding the passage of time as it occurs are also two common symptoms. Planning for future events can become difficult because they arent immediately occurring.

As symptoms progress, people with AD can become increasingly forgetful about where they are, how they got there, or why theyre there.

Artificial Intelligence Could Spot The Early Signs Of Dementia From A Simple Brain Scan Long Before Major Symptoms Appear And In Some Cases Before Any Symptoms Appear Say Cambridge Researchers

Dementias are characterised by the build-up of different types of protein in the brain, which damages brain tissue and leads to cognitive decline. In the case of Alzheimers disease, these proteins include beta-amyloid, which forms plaques, clumping together between neurons and affecting their function, and tau, which accumulates inside neurons.

Molecular and cellular changes to the brain usually begin many years before any symptoms occur. Diagnosing dementia can take many months or even years. It typically requires two or three hospital visits and can involve a range of CT, PET and MRI scans as well as invasive lumber punctures.

A team led by Professor Zoe Kourtzi at the University of Cambridge and The Alan Turing Institute has developed machine learning tools that can detect dementia in patients at a very early stage. Using brain scans from patients who went on to develop Alzheimers, their machine learning algorithm learnt to spot structural changes in the brain. When combined with the results from standard memory tests, the algorithm was able to provide a prognostic score that is, the likelihood of the individual having Alzheimers disease.

MRI brain scan of healthy volunteer

MRI brain scan of healthy volunteer

MRI brain scan of Alzheimer’s patient

MRI brain scan of Alzheimer’s patient

“In time, we hope to be able to identify patients as early as five to ten years before they show symptoms as part of a health check. Professor Zoe Kourtzi, Department of Psychology

Also Check: How To Calm Alzheimer’s Patients

Reviewing Health History And Mental State

If you are experiencing troubling changes in memory, behavior, or thinking abilities, make an appointment to discuss your concerns with a doctor, even if it seems scary.

Primary-care physicians often oversee the diagnostic process but may refer patients to a specialist such as a neurologist, neuropsychologist, geriatrician, or geriatric psychiatrist.

An Alzheimers assessment will include the following:

• Medical and Family History Your history includes past and present illnesses, any medications you take, and any conditions affecting other members of your family.
• Mood Assessment The doctor will look for signs of depression or other mental-health disorders that can cause memory problems or other dementia-like symptoms.

Alzheimer’s Disease Is A Brain Disorder With Symptoms Appearing After Much Of The Damage Is Done But The Good News Is A Blood Test Is Likely To Arrive Soon That Will Help In The Detection Of This Condition Quite Early On

Written by Saswati Sarkar | Updated : June 3, 2020 9:45 PM IST

Alzheimer’s Disease, a neurodegenerative disorder of the brain, affects millions all across the world. Living with this condition, characterised by decline of memory and other cognitive skills like thinking and reasoning, can be a real challenge. What makes it even more challenging is the fact that the symptoms appear decades after much of the damage has been done. So, catching the early signs of this neurological degeneration is very crucial for the management of Alzheimer’s Disease. In a recent development, scientists have identified a biomarker that can detect this condition much earlier than the symptoms occur. The name of the biomarker is Neurofilament light chain . Reported in The Lancet Neurology journal, this latest development is surely a ray of hope for people living with Alzheimer’s Disease.

Recommended Reading: Can An Mri Diagnose Alzheimer’s

Is There A Blood Test For Diagnosing Alzheimers

Researchers are working to diagnose Alzheimers disease at its earliest stages, before the onset of symptoms and even before toxic changes in the brain begin to cause damage.

Their efforts involve the search for new biomarkers measurable, accurate, and reliable indicators of disease that might appear on a blood test, for instance.

These biomarkers may one day help doctors and other clinicians detect Alzheimers early in the disease process, in the same way that increased cholesterol levels in the blood indicate heart disease risk.

For now, the use of Alzheimers biomarkers is mainly limited to research studies, although doctors sometimes use them in clinical practice to help confirm an Alzheimers diagnosis.

Researchers currently use blood tests to look for the presence of certain proteins associated with Alzheimers, including beta amyloid and tau . Scientists are getting closer to developing blood tests that could be used as a routine tool for identifying Alzheimers or screening people who are at risk of developing the disease.

Another biomarker involves cerebrospinal fluid , the clear liquid that surrounds the brain and spinal cord, which can be analyzed for the presence of Alzheimers-related proteins. Tests measuring CSF biomarkers are more sensitive than blood tests and are particularly useful for the diagnosis of early onset Alzheimers.

RELATED: Speaking Alzheimers: A Glossary of Common Terms